After The Stock Fell -38.11% Over The Week, Is PDS Biotechnology Corporation (NASDAQ: PDSB) Still A Buy?
PDS Biotechnology Corporation (NASDAQ:PDSB)’s traded shares stood at 2.19 million during the latest session, with the company’s beta value hitting 1.91. At the last check